Pais / Región
Paises

Provincias / Departamentos
Colombia Colombia
Argentina Argentina
Canada Canada
Chile Chile
Ecuador Ecuador
España España
Guatemala Guatemala
Honduras Honduras
Mexico Mexico
Panama Panama
Paraguay Paraguay
United States United States
Uruguay Uruguay
Categorias / Industrias
Publication: 2021-10-15 15:58:00
United States SAM

Adenovirus Type 4 and Type 7 Vaccine Activities for Modernization

Process Number W81XWH-22-RFI-TD4-01

USA

Dates:


Notice ID:

W81XWH-22-RFI-TD4-01

Department/Ind. Agency:

DEPT OF DEFENSE

Sub-tier:

DEPT OF DEFENSE

Sub Command:

W4PZ USA MED RSCH ACQUIS ACT

Office:

W4PZ USA MED RSCH ACQUIS ACT

General Information:


All Dates/Times are:

(UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA

Updated Published Date:

(UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date:

2021-10-15 15:58:00

Original Response Date:

Nov 05, 2021 03:00 pm EDT

Inactive Policy:

15 days after response date

Original Inactive Date:

Nov 20, 2021

Initiative:
  • None***--***

Classification:


Product Service Code:

6505 - DRUGS AND BIOLOGICALS

NAICS Code:

325412 - Pharmaceutical Preparation Manufacturing

Description:


Original Set Aside:

Please review the attached Request for Information (RFI).

Attachments / Links:


Document Size Updated date Download

Contact Information:


BLDG 820 PBO 820 CHANDLER STREET

FORT DETRICK , MD 21702-5014

USA

Primary Point of Contacts:

Toloria DuVall

Secondary Point of Contact:

Michael Hasty